Research & Development in
Plan-Les-Ouates

STMicroelectronics SA

Since 1984 · 21–50 empl.·4.3(44)

STMicroelectronics SA develops and sells semiconductor solutions and devices for industrial, automotive, communications, energy, and personal electronics applications. Its portfolio includes microcontrollers and microprocessors, sensors, power semiconductors, connectivity products, and embedded software tools.

Contexa SA

Since 1999 · 51–100 empl.·4.1(9)

The company Contexa develops and manufactures innovative dosing and automation systems for the perfume and flavor industry. The core activity of the company is to offer customized solutions for the dosing and automation of perfume and flavor manufacturing processes, in order to improve the efficiency, flexibility and quality of production.

Surcotec SA

Since 1995 · 11–20 empl.·4.0(4)

The core activity of Surcotec encompasses two main areas: 1. **Surface Coatings**: Surcotec offers surface coatings based on PVD, PVD-PECVD, and ALD technologies for decorative or functional applications. 2. **Industrial Analysis**: The company is also a laboratory for industrial analysis and provides services such as surface or embedding characterization, pollution and defect analysis, purity and failure analysis. Overall, Surcotec focuses on the development and application of surface coatings and the performance of industrial analyses.

Selexis SA

Since 2001 · 1–10 empl.

Selexis SA develops and provides technologies and services for mammalian cell line development, with a focus on biopharmaceutical production. The company also presents its SUREtechnology platform for stable CHO-based cell line development.

e-novent SA

Since 2001 · 1–10 empl.

e-novent SA is an engineering firm that supports technical innovation projects and provides services including problem identification and analysis, solution development, feasibility and patentability studies, and implementation support.

ANTION BIOSCIENCES SA

Since 2011 · 1–10 empl.

ANTION BIOSCIENCES SA develops a proprietary gene engineering technology and a multiplex engineering platform to support development and manufacturing of cell and gene therapy products. The company offers partnering, business development and related services, and publishes scientific work on its technology.

APTISSEN SA

Since 2013 · 51–100 empl.

Aptissen develops and distributes medical products, particularly orthobiological solutions for the treatment of muscle and joint pain. The company's core activities include research, development and marketing of products such as Synolis VA and Cartylis, which are used for tissue regeneration and repair.

KYLANE LABORATOIRES SA

Since 2016 · 1–10 empl.

The core activity of Kylane Laboratoires is the development, manufacture and marketing of innovative, hyaluronic acid (HA) based solutions for aesthetic medicine, particularly for the treatment of the face and body.

DEASYL SA

Since 2017 · 11–20 empl.

DEASYL SA develops green chemical processes and provides eco-friendly alternatives to conventional polluting methods. The company applies its patented Impact in Continuous flow Heated Mechanochemistry (ICHEM) approach to reduce energy use, improve yields and selectivity, and convert waste and biomass into higher-value products.

KEP Innovation Center SA

Since 2017 · 21–50 empl.

KEP Innovation Center SA is the innovation center of KEP Technologies and develops radioactivity measurement solutions, notably using halogenated perovskites. It conducts R&D on crystal synthesis and supplies perovskite crystals for the development of detection and alarm devices as well as for industrial and medical applications.

FluoSphera SA

Since 2021 · 11–20 empl.

The core activity of FluoSphera is the development and application of microphysiological systems to predict the effects of molecules and thus support the discovery of effective medicines with fewer side effects.

OncoTheis Sàrl

Since 2014 · 1–10 empl.